サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1784835

ガラス化の世界市場

Vitrification

出版日
ページ情報
英文 278 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
ガラス化の世界市場
出版日: 2025年08月06日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 278 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ガラス化の世界市場は2030年までに221億米ドルに到達

2024年に92億米ドルと推定されるガラス化の世界市場は、2024～2030年の分析期間においてCAGR 15.7%で成長し、2030年には221億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである卵母細胞は、CAGR 16.5%を記録し、分析期間終了時には125億米ドルに達すると予測されます。デバイス分野の成長率は、分析期間中CAGR 14.0％と推定されます。

米国市場は25億米ドル、中国はCAGR 20.9％で成長予測

米国のガラス化市場は、2024年に25億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに48億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは20.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.5％と14.1％と予測されています。欧州では、ドイツがCAGR約12.5%で成長すると予測されています。

世界のガラス化市場- 主要動向と促進要因のまとめ

ガラス化が凍結保存のブレークスルーとして台頭しているのはなぜか？

ガラス化は凍結保存の分野に革命を起こし、胚、卵子、幹細胞、組織などの生物学的標本を保存するための非常に効率的な方法を提供しています。従来の緩慢凍結技術とは異なり、ガラス化は細胞構造に損傷を与える氷の結晶を形成することなく、生物学的材料を急速にガラスのような状態まで冷却します。この高度な凍結保存法は、生殖補助医療（ART）、特に体外受精（IVF）クリニックで広く採用されており、生存率の著しく高い胚や卵子の保存に用いられています。親になるのが遅れる傾向、生殖能力に影響を与える治療、生殖医療の進歩などにより、生殖能力温存の需要が増加しているため、ART治療におけるガラス化の必要性が高まっています。さらに、ガラス化は、再生医療、バイオバンク、臓器移植研究において重要な役割を果たしています。そこでは、生存可能な生物学的材料の長期保存が、将来の医学的ブレークスルーのために不可欠です。クライオバイオロジーの科学的理解が進むにつれて、ガラス化は複数の医療および研究用途における凍結保存のゴールドスタンダードになることが期待されています。

技術の進歩は、ガラス化技術をどのように向上させていますか？

凍結保存技術における絶え間ない技術革新により、ガラス化の効率、生存率、保存能力は大幅に改善されました。超急速冷却技術と高度な凍結保護剤溶液の開発により、解凍後の生存率を高めながら、細胞損傷のリスクを最小限に抑えています。自動化されたガラス化システムも導入され、不妊治療クリニックや研究所における人為的ミスを減らし、凍結手順を標準化しています。さらに、閉鎖系ガラス化装置などの凍結保存システムの改良は、汚染の懸念に対処し、保存された生物学的サンプルの無菌性と長期的安全性を保証しています。ナノテクノロジーは、ガラス化研究においても新たな役割を果たしており、科学者たちは凍結・融解時の細胞の完全性をさらに向上させるナノ強化凍結保護剤を探求しています。さらに、凍結保存プロトコルのAIによる最適化は、研究者や臨床医が個々の生物学的特性に基づいて凍結条件をカスタマイズできるようにし、ガラス化の成果を高めています。これらの技術的進歩は、ガラス化の信頼性を向上させるだけでなく、再生医療、遺伝子保存、臓器移植研究への応用の可能性を広げています。

ガラス化の凍結保存への導入を阻む課題とは？

ガラス化は、従来の凍結方法と比較して優れた効率性を持っているにもかかわらず、医療や研究現場での普及に影響を与えるいくつかの課題に直面しています。主な障害の一つは、ガラス化装置、特殊な凍結保護剤、凍結保存施設に関連する高コストであり、リソースの乏しいヘルスケア環境では利用しにくいです。さらに、この技術には高度な専門知識と精度が要求されるため、一貫した結果を得るためには、胚培養士、生物学者、検査技師に広範なトレーニングが必要となります。もうひとつの課題は、ヒト胚や生殖細胞の長期保存をめぐる倫理的・法的考察にあります。さらに、長期保存に伴うガラス化細胞の遺伝的・構造的完全性に関する懸念は、現在も研究中の分野です。これらの課題に対処するには、費用対効果の高い凍結保存法の継続的な進歩、標準化されたトレーニングプロトコル、ガラス化生物試料の長期生存性に関するより包括的な研究が必要となります。

ガラス化市場の成長を促進する要因は何か？

ガラス化市場の成長は、不妊治療需要の増加、再生医療の進歩、バイオバンクと遺伝子研究の拡大など、いくつかの要因によってもたらされます。不妊症の世界の有病率の上昇と体外受精治療の受け入れ拡大は、生殖医療におけるガラス化の採用に大きく貢献しています。さらに、幹細胞治療や臓器保存研究の拡大により、将来の医療応用のために細胞の生存性を維持する信頼性の高い凍結保存方法に対する需要が高まっています。現在進行中の個別化医療と遺伝子保存ソリューションの開発は、生物学的多様性と希少遺伝物質を保存するための重要なツールとして、ガラス化への関心をさらに高めています。凍結保護剤、自動化、AIによる凍結最適化の絶え間ない革新により、ガラス化市場は大幅な成長を遂げ、生殖医療、生物医学研究、長期的な生物学的保存の未来を形成しています。

セグメント

検体（卵子、デバイス、精子）;エンドユース（IVFクリニック、バイオバンク）

調査対象企業の例

  • Biotech, Inc.
  • Cook Medical, LLC
  • CooperSurgical, Inc.
  • Cryoport Systems, Inc.
  • Fertipro NV
  • FUJIFILM Irvine Scientific d/b/a FUJIFILM Biosciences
  • Genea Biomedx
  • GYNEMED GmbH & Co. KG
  • Imv Technologies S.A.
  • KITAZATO CORPORATION

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP33309

Global Vitrification Market to Reach US$22.1 Billion by 2030

The global market for Vitrification estimated at US$9.2 Billion in the year 2024, is expected to reach US$22.1 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Oocytes, one of the segments analyzed in the report, is expected to record a 16.5% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Devices segment is estimated at 14.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 20.9% CAGR

The Vitrification market in the U.S. is estimated at US$2.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global Vitrification Market - Key Trends & Drivers Summarized

Why Is Vitrification Emerging as a Breakthrough in Cryopreservation?

Vitrification has revolutionized the field of cryopreservation, offering a highly efficient method for preserving biological specimens such as embryos, oocytes, stem cells, and tissues. Unlike traditional slow-freezing techniques, vitrification rapidly cools biological materials to a glass-like state without forming ice crystals, which can damage cellular structures. This advanced cryopreservation method has gained widespread adoption in assisted reproductive technology (ART), particularly in in-vitro fertilization (IVF) clinics, where it is used to preserve embryos and eggs with significantly higher survival rates. The increasing demand for fertility preservation, driven by delayed parenthood trends, medical treatments affecting fertility, and advancements in reproductive medicine, has fueled the need for vitrification in ART procedures. Additionally, vitrification is playing a crucial role in regenerative medicine, biobanking, and organ transplantation research, where the long-term storage of viable biological materials is essential for future medical breakthroughs. As scientific understanding of cryobiology continues to advance, vitrification is expected to become the gold standard for cryopreservation across multiple medical and research applications.

How Are Technological Advancements Improving Vitrification Techniques?

Continuous innovations in cryopreservation technology have led to significant improvements in vitrification efficiency, survival rates, and storage capabilities. The development of ultra-rapid cooling techniques and advanced cryoprotectant solutions has minimized the risks of cellular damage while enhancing post-thaw viability. Automated vitrification systems have also been introduced, reducing human error and standardizing freezing procedures in fertility clinics and research laboratories. Additionally, improvements in cryo-storage systems, such as closed-system vitrification devices, have addressed contamination concerns, ensuring the sterility and long-term safety of stored biological samples. Nanotechnology is also playing an emerging role in vitrification research, with scientists exploring nano-enhanced cryoprotectants that further improve cell integrity during freezing and thawing. Moreover, AI-driven optimization of cryopreservation protocols is enhancing vitrification outcomes, allowing researchers and clinicians to customize freezing conditions based on individual biological characteristics. These technological advancements are not only improving the reliability of vitrification but also expanding its potential applications in regenerative medicine, genetic preservation, and organ transplantation research.

What Challenges Are Hindering the Adoption of Vitrification in Cryopreservation?

Despite its superior efficiency compared to traditional freezing methods, vitrification faces several challenges that impact its widespread implementation in medical and research settings. One of the primary obstacles is the high cost associated with vitrification equipment, specialized cryoprotectants, and cryo-storage facilities, making it less accessible in low-resource healthcare environments. Additionally, the technique requires a high level of expertise and precision, necessitating extensive training for embryologists, biologists, and laboratory technicians to achieve consistent results. Another challenge lies in the ethical and legal considerations surrounding the long-term storage of human embryos and reproductive cells, as different countries have varying regulations governing cryopreservation practices. Furthermore, concerns regarding the potential genetic and structural integrity of vitrified cells over extended storage periods remain an area of ongoing research. Addressing these challenges will require continued advancements in cost-effective cryopreservation methods, standardized training protocols, and more comprehensive studies on the long-term viability of vitrified biological specimens.

What Factors Are Driving the Growth of the Vitrification Market?

The growth in the vitrification market is driven by several factors, including the increasing demand for fertility preservation, advancements in regenerative medicine, and the expansion of biobanking and genetic research. The rising global prevalence of infertility and the growing acceptance of IVF treatments have significantly contributed to the adoption of vitrification in reproductive medicine. Additionally, the expansion of stem cell therapies and organ preservation research has increased the demand for reliable cryopreservation methods that maintain cellular viability for future medical applications. The ongoing development of personalized medicine and genetic storage solutions has further fueled interest in vitrification as a critical tool for preserving biological diversity and rare genetic materials. With continuous innovations in cryoprotectants, automation, and AI-driven cryo-optimization, the vitrification market is poised for substantial growth, shaping the future of reproductive health, biomedical research, and long-term biological preservation.

SCOPE OF STUDY:

The report analyzes the Vitrification market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Specimen (Oocytes, Devices, Sperm); End-Use (IVF Clinics, Biobanks)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Biotech, Inc.
  • Cook Medical, LLC
  • CooperSurgical, Inc.
  • Cryoport Systems, Inc.
  • Fertipro NV
  • FUJIFILM Irvine Scientific d/b/a FUJIFILM Biosciences
  • Genea Biomedx
  • GYNEMED GmbH & Co. KG
  • Imv Technologies S.A.
  • KITAZATO CORPORATION

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Vitrification - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Accelerating Demand for Fertility Preservation Solutions Drives Adoption of Vitrification Technologies
    • Breakthroughs in Cryobiology Research Strengthen the Scientific Case for Vitrification Over Slow Freezing
    • Rising IVF Success Rates Through Vitrification Expands Addressable Market in Assisted Reproductive Technologies
    • Increasing Oncology Cases and Fertility Preservation Among Cancer Patients Spurs Growth in Medical Applications
    • Growing Demand for Oocyte and Embryo Banking Throws the Spotlight on Vitrification as the Preferred Cryopreservation Method
    • Technological Advancements in Cryoprotectants and Warming Protocols Enhance Viability and Post-Thaw Survival
    • Regulatory Approvals and Guidelines for Embryo and Gamete Storage Boost Clinical Adoption of Vitrification
    • Expansion of Egg Donation and Surrogacy Programs Generates Accelerated Demand for Vitrification-Based Cryostorage
    • Rising Global Awareness of Fertility Options Among Women in Career-Oriented Demographics Drives Uptake
    • Increased Usage of Vitrification in Livestock Embryo Preservation Propels Agricultural and Veterinary Applications
    • Integration of Vitrification with Time-Lapse Imaging and AI-Driven Embryo Selection Optimizes IVF Outcomes
    • Surge in Cross-Border Reproductive Care Expands Global Demand for Safe and Efficient Cryostorage
    • Demand for Long-Term Cell and Tissue Preservation in Stem Cell and Regenerative Medicine Sustains Market Growth
    • Emergence of Portable Vitrification Devices Spurs Decentralized Cryopreservation Capabilities in Remote Clinics
    • Growth of Fertility Tech Startups and Cryobank Infrastructure Strengthens Business Case for Market Investment
    • Collaborative Research on Cryopreservation of Organoids and 3D Cell Cultures Expands Therapeutic Use Cases
    • Adoption of Vitrification for Sperm Preservation in High-Performance Animal Breeding Opens New Revenue Streams
    • Ethical, Legal, and Storage Duration Considerations Create Challenges and Opportunities for Policy Innovation
    • Use of Vitrification in Preservation of Endangered Species Strengthens Conservation Biology Applications
    • Demand for Cost-Effective Cryopreservation Solutions in Emerging Markets Drives Technology Localization
    • Rising Investments in Cell Therapy Manufacturing Infrastructure Throws the Spotlight on Vitrification's Role in Biobanking
    • Public and Private Initiatives to Expand Reproductive Health Services Propel Adoption of Vitrification in Clinical Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vitrification Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vitrification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vitrification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oocytes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oocytes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Oocytes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Sperm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Sperm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Sperm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for IVF Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for IVF Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for IVF Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • JAPAN
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • CHINA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • EUROPE
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Vitrification by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Vitrification by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • FRANCE
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • GERMANY
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Vitrification by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • INDIA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Vitrification by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Vitrification by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • AFRICA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030

IV. COMPETITION